Teradyne (TER) Tops Q3 EPS by 6c, provides guidance

Teradyne (NASDAQ: TER) reported Q3 EPS of $0.85, $0.06 better than the analyst estimate of $0.79. Revenue for the quarter came in at $769 million versus the consensus estimate of $743.78 million.

GUIDANCE:

Teradyne sees Q4 2025 EPS of $1.20-$1.46, versus the consensus of $1.03. Teradyne sees Q4 2025 revenue of $920-1000 million, versus the consensus of $815.7 million.

For earnings history and earnings-related data on Teradyne (TER) click here.

You May Also Be Interested In

• Oman Warned European Allies Ship Fees Likely Needed For Hormuz - Bloomberg
• Wendy's (WEN) call put ratio 3.5 calls to 1 put with a focus on 2800 contracts of July 9 calls
• Baird Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)